RECOVERY / SINGLE
BPC-157
5MG · 10MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A pentadecapeptide fragment studied mainly in preclinical models of gut, tendon, ligament and muscle-tissue repair.
Available Strengths
- 5MG (BC5)
- 10MG (BC10)
Research Protocol
Reference gradual schedule
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.2 mg | 12 | 0.12 mL |
| Weeks 3–4 | 0.4 mg | 24 | 0.24 mL |
| Weeks 5–8+ | 0.6 mg | 36 | 0.36 mL |
Reconstitution
≈1.67 mg/mL once reconstituted
- Draw 3.0 mL of bacteriostatic water per 5 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved. Do not shake.
- Allow the vial to reach room temperature before opening to limit condensation.
Research context
Discussed in preclinical research as modulating nitric-oxide pathways and growth-factor expression, associated with angiogenesis and collagen deposition in damaged tissue models.
Storage
−20°C, dry and dark, minimal moisture exposure. 2–8°C, avoid freeze-thaw cycles.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
- Human clinical efficacy and long-term safety data remain limited in the cited literature.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source